Generic Drug Alert: FDA Approves Generic Version of Neurontin to Treat CNS Disorders

Quick generic drug approval bulletin for today. If you or a loved one suffers from central nervous system (CNS) disorders, this generic drug alert is for you. Aurobindo Pharmaceuticals has announced that the Food and Drug Administration has approved the release of its generic gabapentin tablets, a generic version of Pfizer’s prescription drug Neurontin which treats CNS disorders.

According to the Mayo Clinic, CNS inflammatory demyelinating disorders affect at least 400,000 patients in the United States and account for the most common disabling neurological diseases of young adults. More than 50 percent of patients are significantly disabled..

Considering a thirty-day supply of brand-name Neurontin is currently running almost $200, generic Neurontin tablets could easily be a major savings for many CNS disorder patients and their families.

Does someone in your family use Neurontin? Tell us about it!

Related posts:

1. Generic Drug Alert: FDA Approves Generic Version of Epilepsy Drug Neurontin
2. Generic Drug Alert: FDA Approves Generic Version of Famvir To Treat Herpes
3. Generic Drug Alert: FDA Approves Generic Version of Breast Cancer Drug Arimidex
4. Generic Drug Alert: FDA Approves Generic Version of Precose for Type 2 Diabetes
5. Generic Drug Alert: FDA Approves New Generic Version of Breast Cancer Drug Femara